Pulmatrix Inc./$PULM
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About Pulmatrix Inc.
Pulmatrix Inc is a biopharmaceutical company focused on the development of novel inhaled therapeutic products intended to prevent and treat migraine and respiratory diseases with important unmet medical needs using its patented dry powder delivery technology, iSPERSE. Its pipeline of clinical assets includes PUR3100 for the treatment of acute migraine, PUR1800 for the treatment of acute exacerbations of chronic obstructive pulmonary disease (AECOPD), and PUR1900 for the treatment of ABPA in patients with asthma and in patients with cystic fibrosis (CF).
Ticker
$PULM
Sector
Primary listing
Employees
2
Headquarters
Website
Pulmatrix Inc. Metrics
BasicAdvanced
$5.5m
-
-$1.24
1.94
-
Price and volume
Market cap
$5.5m
Beta
1.94
52-week high
$9.15
52-week low
$1.16
Average daily volume
23k
Financial strength
Current ratio
4.96
Quick ratio
3.673
Profitability
Management effectiveness
Return on assets (TTM)
-45.97%
Return on equity (TTM)
-84.30%
Valuation
Price to book
2.07
Price to tangible book (TTM)
2.07
Price to free cash flow (TTM)
-1.169
Free cash flow yield (TTM)
-85.55%
Free cash flow per share (TTM)
-1.283
Growth
Earnings per share change (TTM)
-62.88%
3-year earnings per share growth (CAGR)
-37.92%
10-year earnings per share growth (CAGR)
-45.25%
Pulmatrix Inc. News
AllArticlesVideos
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
FAQs